Rosiglitazone Ameliorates Spinal Cord Injury via Inhibiting Mitophagy and Inflammation of Neural Stem Cells.
Qingqi MengZhiteng ChenQing-Yuan GaoLiqiong HuQilong LiShutai LiLili CuiZhencheng FengXingliang ZhangShiyun CuiHai-Feng ZhangPublished in: Oxidative medicine and cellular longevity (2022)
Besides inflammation inhibition, Rosi suppressed mitophagy by reducing FOXO1 to decrease the transcription of PINK1, which played a pivotal role in accelerating the NSC proliferation.